TY - JOUR
T1 - Fecal microbiota transplantation is associated with reduced morbidity and mortality in porcine circovirus associated disease
AU - Niederwerder, Megan C.
AU - Constance, Laura A.
AU - Rowland, Raymond R.R.
AU - Abbas, Waseem
AU - Fernando, Samodha C.
AU - Potter, Megan L.
AU - Sheahan, Maureen A.
AU - Burkey, Thomas E.
AU - Hesse, Richard A.
AU - Cino-Ozuna, Ada G.
N1 - Funding Information:
The authors thank Dr. Lisa Tokach, Dr. Brooke Bloomberg, Cathy Troupe, Ana Stoian, Vlad Petrovan, Josh Springfield, and Andrew Suddith for sample collection, animal care, and laboratory research support. This work was supported by the Kansas State University College of Veterinary Medicine Success for Young Investigators Grant Program, start-up funds from Kansas State University College of Veterinary Medicine, and the State of Kansas National Bio and Agro-Defense Facility Fund.
PY - 2018/7/23
Y1 - 2018/7/23
N2 - Porcine circovirus associated disease (PCVAD) is a term used to describe the multi-factorial disease syndromes caused by porcine circovirus type 2 (PCV-2), which can be reproduced in an experimental setting through the co-infection of pigs with PCV-2 and porcine reproductive and respiratory syndrome virus (PRRSV). The resulting PCVAD-affected pigs represent a subpopulation within the co-infected group. In co-infection studies, the presence of increased microbiome diversity is linked to a reduction in clinical signs. In this study, fecal microbiota transplantation (FMT) was investigated as a means to prevent PCVAD in pigs co-infected with PRRSV and PCV-2d. The sources of the FMT material were high-parity sows with a documented history of high health status and robust litter characteristics. The analysis of the donated FMT material showed the absence of common pathogens along with the presence of diverse microbial phyla and families. One group of pigs (n = 10) was administered the FMT while a control group (n = 10) was administered a sterile mock-transplant. Over the 42-day post-infection period, the FMT group showed fewer PCVAD-affected pigs, as evidenced by a significant reduction in morbidity and mortality in transplanted pigs, along with increased antibody levels. Overall, this study provides evidence that FMT decreases the severity of clinical signs following co-infection with PRRSV and PCV-2 by reducing the prevalence of PCVAD.
AB - Porcine circovirus associated disease (PCVAD) is a term used to describe the multi-factorial disease syndromes caused by porcine circovirus type 2 (PCV-2), which can be reproduced in an experimental setting through the co-infection of pigs with PCV-2 and porcine reproductive and respiratory syndrome virus (PRRSV). The resulting PCVAD-affected pigs represent a subpopulation within the co-infected group. In co-infection studies, the presence of increased microbiome diversity is linked to a reduction in clinical signs. In this study, fecal microbiota transplantation (FMT) was investigated as a means to prevent PCVAD in pigs co-infected with PRRSV and PCV-2d. The sources of the FMT material were high-parity sows with a documented history of high health status and robust litter characteristics. The analysis of the donated FMT material showed the absence of common pathogens along with the presence of diverse microbial phyla and families. One group of pigs (n = 10) was administered the FMT while a control group (n = 10) was administered a sterile mock-transplant. Over the 42-day post-infection period, the FMT group showed fewer PCVAD-affected pigs, as evidenced by a significant reduction in morbidity and mortality in transplanted pigs, along with increased antibody levels. Overall, this study provides evidence that FMT decreases the severity of clinical signs following co-infection with PRRSV and PCV-2 by reducing the prevalence of PCVAD.
KW - Fecal microbiota transplantation
KW - Microbiome
KW - Porcine circovirus associated disease
KW - Porcine circovirus type 2
KW - Porcine reproductive and respiratory syndrome virus
KW - Swine
UR - http://www.scopus.com/inward/record.url?scp=85050308976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050308976&partnerID=8YFLogxK
U2 - 10.3389/fmicb.2018.01631
DO - 10.3389/fmicb.2018.01631
M3 - Article
AN - SCOPUS:85050308976
VL - 9
JO - Frontiers in Microbiology
JF - Frontiers in Microbiology
SN - 1664-302X
IS - JUL
M1 - 1631
ER -